bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $106.00 and traded as low as $103.50. bioMérieux shares last traded at $103.50, with a volume of 10 shares changing hands.
bioMérieux Stock Performance
The firm has a fifty day moving average of $106.00 and a 200-day moving average of $108.07.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
See Also
- Five stocks we like better than bioMérieux
- Which Wall Street Analysts are the Most Accurate?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
